Skip to content
Home/Companies/Biotech/ASTRA Therapeutics

ASTRA Therapeutics

Biotech·Germany·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns ASTRA Therapeutics?

ASTRA Therapeutics is a German Biotech company, currently owned by MIG Capital since 2025.

Hand-verified · updated 2026-07-03

Open JSON · CC-BY
MIG Capital
Investor
MIG Capital
MIG Fonds 17 · 2022 · Evergreen

Key facts

HQGermany
SectorBiotech
StatusActive

More from MIG Fonds 17

Other portfolio companies in the same fund.

GlassPoint
Active
ClimateTechUS· 2024
HawkCell
Active
MedTechFrance· 2024
SciRhom
Active
BiotechGermany· 2024
Look Up Space
Active
Aerospace & DefenceFrance· 2023
TALPA Solutions
TALPA Solutions
Active
Data & AnalyticsGermany· 2023
German Bionic
German Bionic
Exited 2025
LogisticsGermany· 2020
to Archimedes Partners

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns ASTRA Therapeutics?

ASTRA Therapeutics is currently owned by MIG Capital, through MIG Fonds 17, since 2025.

When did MIG Capital acquire ASTRA Therapeutics?

MIG Capital acquired ASTRA Therapeutics in 2025.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue